As a new biological drug, belimumab has attracted much attention for its efficacy and safety. As one of the commonly used packaging forms for biopharmaceuticals, CZ vials have become the ideal packaging for belimumab because of their high transparency, stable chemical properties, and low protein adsorption.
RTU(ready to use) 2ml COP vial
The Crystal Zenith Vial is a transparent bottle-shaped packaging container made of polymer material. Its characteristics mainly include the following aspects.
First of all, its material is cyclic olefin polymer, which has high transparency. The drug in the bottle can be clearly observed, making it easier for users to monitor the status of the drug.
Secondly, its chemical properties are stable and can effectively protect medicines from interference from the external environment.
In addition, this packaging material has low protein adsorption, which can reduce the interaction between drugs and packaging materials and avoid affecting the effectiveness and stability of drugs.
Belimumab is a human antibody that targets a protein called B lymphocyte stimulating factor (BLyS). In SLE patients, the immune system is abnormally activated, leading to the development of autoimmune diseases. By inhibiting the action of BLyS, belimumab reduces the activity of B lymphocytes and reduces abnormal responses of the immune system. The good performance of CZ vials can provide very good protection for belimumab, making it an ideal packaging choice.
In short, CZ vials play an important role in the packaging of belimumab due to their high transparency, stable chemical properties, and low protein adsorption. Through continuous research and improvement, it is believed that this kind of packaging will play a more extensive role in future biopharmaceutical packaging.
Copyright © Shijiazhuang Xinfuda Medical Packaging Co., Ltd. All Rights
MAKE AN ENQUIRY
